»
S
I
D
E
B
A
R
«
About this site
Apr 19th, 2009 by Administrator

This site welcomes original publications, review articles, case records in the field of neurology, psychiatry, neuroradiology, neuropathology, and neurosurgery

  • Share/Bookmark
Radiological quiz
Mar 7th, 2010 by Administrator

The author: Professor Yasser Metwally

http://yassermetwally.com


INTRODUCTION

March  7, 2010 — Radiological quiz

 
Radiological quiz. What is your diagnosis

Click to download the answer in PDF format

Click to download slide show in PDF format


References

  1. Metwally, MYM: Textbook of neuroimaging, A CD-ROM publication, (Metwally, MYM editor) WEB-CD agency for electronic publication, version 11.1a January 2010 [Click to have a look at the home page]
  • Share/Bookmark
Thyroid ophthalmopathy: A CT scan approach
Mar 6th, 2010 by Administrator

The author: Professor Yasser Metwally

http://yassermetwally.com


INTRODUCTION

March  6, 2010 — Thyroid ophthalmopathy is characterized by inflammation, congestion, hypertrophy, and fibrosis of the orbital fat and muscles leading to enlargement of tissue, especially the extraocular muscles. The extraocular muscles are enlarged, firm, rubbery, and dark red. The histologic findings,that are related to the severity and stage of the disease, consist of interstitial edema and inflammatory cell infiltrates. The inflammatory cells are composed of lymphocytes, plasma cells, and occasional mast cells (B lymphocytes in 80% and T lymphocytes in 20%). The inflammatory reaction, predominantly in the muscle, can also occur in the tendons. The inflammatory reactions are predominantly localized in the endomysial connective tissue with extension to the perimysium and epimysium surrounding the extraocular muscles in the late stage. There is a fibroblast reaction with production of mucopolysaccharides, specifically, hyaluronic acid, characterized by glucose aminoglycons. In the later stages of severe ophthalmopathy, there is fibrosis and fatty infiltrations of muscles resulting in a restrictive myopathy. In general the most common findings in Graves’ disease are extraocular muscles enlargement and expansion of the orbital fat.

Click to enlarge figure

Figure 1. Thyroid ophthalmopathy (Click to enlarge figure)

  • Extraocular muscles enlargement

The diagnosis of Graves’ disease is often established by clinical means. CT is the preferred imaging modality for the evaluation of Graves’ disease in cases where the diagnosis is uncertain. Furthermore, CT is used to assess extra-ocular muscle enlargement, fatty expansion, and optic nerve compression, especially prior to surgery and as a follow-up after treatment. This examination should be carried out with 4- to 5-mm-thick sections in the axial and coronal planes. This allows detailed assessment of extraocular muscle enlargement, which provides the most important parameter in the diagnosis. The enlarged muscles are spindle- shaped with the belly reflecting the muscular portion and the tapered, anterior end, the tendinous portion. Occasionally, the muscular tendons may be slightly enlarged. On MR imaging, the normal muscle is characterized by low signal intensity on the Tl-weighted images and intermediate signal intensity on the T2- weighted images. There is marked enhancement of the extraocular muscles following the introduction of gadolinium, which is in contrast to muscles in other body parts, which reveal no enhancement. This is based on the increased vascularity of the extraocular muscles, allowing for diffusion of contrast material into the muscular tissue.

Click to enlarge figure

Figure 2. Sever enlargement of the extraocular muscles. (Click to enlarge figure)

It has been shown that increased extraocular muscle volume correlates with severity of optic neuropathy and, furthermore, improvement of the optic neuropathy appears to correlate with decrease in extraocular muscle swelling at the apex of the muscle cone. Significant enlargement of the medial rectus muscle may lead to remodeling of the lamina papyracea with deviation medially from pressure by the medial rectus muscle.

Click to enlarge figure

Figure 3.  A case of graves disease showing bilateral medial and lateral rectus enlargement. (Click to enlarge figure)

In Graves’ disease, a single muscle may be enlarged such as the medial , inferior and superior rectus muscles. If only axial images are performed, superior and inferior muscle enlargement is easily overlooked and is, therefore, optimally evaluated with coronal sections. Multiple muscles are usually enlarged in Graves’ disease and, not infrequently, both orbits are involved. Sometimes, the patient demonstrates clinical Graves’ disease in one orbit but on the CT study the asymptomatic orbit also reveals enlargement of muscles.

The margins of the muscles are usually well defined. In order of frequency, the inferior rectus is the most common muscle involved in Graves’ ophthalmopathy followed by the medial rectus muscle, and the superior muscle complex composed of the levator-palpebral, and superior rectus muscles. In addition, there is enlargement of the superior oblique muscle, which is optimally demonstrated in the coronal projection.

Click to enlarge figure

Figure 4. A case of graves disease showing bilateral medial and lateral rectus enlargement. (Click to enlarge figure)

The lateral rectus muscle often reveals some enlargement in conjunction with the other extraocular muscles, but this is less pronounced and in most cases the muscle appears normal, whereas the medial and inferior rectus muscles reveal enlargement. The degree of muscle enlargement varies from mild to severe with a significant portion of the orbit obliterated when the muscles are markedly enlarged. Significant muscle enlargement leads to bunching in the apex of the orbit with extrinsic pressure on the optic nerve and consequent loss of vision and field defects.

Click to enlarge figure

Figure 5.  A case of graves disease showing bilateral medial rectus enlargement. (Click to enlarge figure

Click to enlarge figure

Figure 6.  CT scan axial and coronal views (graves ophthalmopathy) showing enlargement of the extraocular muscles, notice that the inferior rectus and superior oblique muscle enlargement could only be appreciated on the coronal views. (Click to enlarge figure)

  • Orbital fat expansion

The second most common finding in Graves’ disease is expansion of the orbital fat. This is difficult to quantify on CT, but is suspected in patients with moderate to marked exophthalmus. Fatty expansion leads to considerable stretching and straightening of the optic nerve. Normally, the nerve is undulated when the globe is in a normal position. Frequently, there is a bulge of the orbital septum anteriorly secondary to extrinsic pressure from the expanded orbital fat. Occasionally, there are increased mottled densities within the orbital fat that, on biopsy, have proved to be lymphocytic infiltrations. Some vascular congestion may also contribute to a slight increase in soft tissue densities within the orbital fat, especially if they are linear in configuration. Slight enlargement of the lacrimal glands is also encountered in patients with Graves’ disease, which is well demonstrated on axial and coronal CT images. Rarely, there may be some slight enlargement of the optic nerve, probably the result of lymphocytic infiltrations in the surrounding orbital fat.

Several other disease entities may be responsible for enlargement of the extraocular muscles and, therefore, enter into the differential diagnosis ; these include:

  • Pseudotumor
  • Carotid cavernous sinus fistula
  • Extradural arteriovenous fistula
  • Metastatic disease
  • Lymphoproliferative disease
  • Acromegaly
  • Amyloidosis
  • Cysticercosis
  • Trichinosis


References

  1. Balazs C, Kiss E, Vamos A: Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO): a pilot study [published erratum appears in J Clin Endocrinol Metab 1997 Sep;82(9):3077]. : a pilot study [published erratum appears in J Clin Endocrinol Metab 1997 Sep; 1997 Jun; 82(6): 1999-2002.
  2. Bartalena L, Marcocci C, Bogazzi F: Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [see comments]. N Engl J Med 1998 Jan 8; 338(2): 73-8.
  3. Bartalena L, Marcocci C, Bogazzi F: A new ophthalmopathy index for quantitation of eye changes of Graves’ disease. Acta Endocrinol 1989; 12 (suppl 2): 190.
  4. Bartley GB, Fatourechi V, Kadrmas EF: The incidence of Graves’ ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 1995 Oct; 120(4): 511-7.
  5. Bartley GB, Gorman CA: Diagnostic criteria for Graves’ ophthalmopathy. Am J Ophthalmol 1995 Jun; 119(6): 792-5.
  6. Bartley GB, Gorman CA: Diagnostic criteria for Graves’ ophthalmopathy. Am J Ophthalmol 1995 Jun; 119(6): 792-5.
  7. Bartley GB: Evolution of classification systems for Graves’ ophthalmopathy. Ophthal Plast Reconstr Surg 1995 Dec; 11(4): 229-37.
  8. Beckendorf V, Maalouf T, George JL: Place of radiotherapy in the treatment of Graves’ orbitopathy. Int J Radiat Oncol Biol Phys 1999 Mar 1; 43(4): 805-15.
  9. Bertelsen JB, Hegedus L: Cigarette smoking and the thyroid. Thyroid 1994 Fall; 4(3): 327-31.
  10. Burke JP, Shipman TC, Watts MT: Convergence insufficiency in thyroid eye disease. J Pediatr Ophthalmol Strabismus 1993 Mar-Apr; 30(2): 127-9.
  11. Char DH: Thyroid Eye Signs and Disease Classification. Thyroid Eye Disease 1997; 3rd: 40.
  12. Coats DK, Paysse EA, Plager DA: Early strabismus surgery for thyroid ophthalmopathy. Ophthalomology 1999; 106: 324-9.
  13. Danks JJ, Harrad RA: Flashing lights in thyroid eye disease: a new symptom described and (possibly) explained. Br J Ophthalmol 1998; 82: 309-11.
  14. Fries PD: Thyroid dysfunction: managing the ocular complications of Graves’ disease. Geriatrics 1992 Feb; 47(2): 58-60, 63-4, 70.
  15. Gorman CA: Temporal relationship between onset of Graves’ ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983 Aug; 58(8): 515-9.
  16. Graves RJ: Newly observed affection of the thyroid gland in females. London Med Surg J 1835; 7: 516.
  17. Hiromatsu Y, Yang D, Miyake I: Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 1998 Jan; 83(1): 121-4.
  18. Ivy HK: Medical approach to ophthalmopathy of Graves’ disease. Mayo Clin Proc 1972 Dec; 47(12): 980-5.
  19. Jacobson DM: Acetylcholine receptor antibodies in patients with Graves’ ophthalmopathy. J Neuroophthalmol 1995 Sep; 15(3): 166-70.
  20. Kadrmas EF, Bartley GB: Superior limbic keratoconjunctivitis. A prognostic sign for severe Graves ophthalmopathy. Ophthalmology 1995 Oct; 102(10): 1472-5.
  21. Kahaly G, Pitz S, Muller-Forell W: Randomized trial of intravenous immunoglobulins versus prednisolone in Graves’ ophthalmopathy. Clin Exp Immunol 1996 Nov; 106(2): 197-202.
  22. Kiljanski JI, Peele K, Stachura I: Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves’ disease be considered a collagen disorder? J Endocrinol Invest 1997 Nov; 20(10): 585-91.
  23. Krassas GE, Kaltsas T, Dumas A: Lanreotide in the treatment of patients with thyroid eye disease. Eur J Endocrinol 1997 Apr; 136(4): 416-22.
  24. Lemke BN, Khwarg SI: Adjuvant lateral canthal advancement in the surgical management of exophthalmic eyelid retraction. Arch Ophthalmol 1999 Feb; 117(2): 274-80.
  25. Ljunggren JG, Torring O, Wallin G: Quality of life aspects and costs in treatment of Graves’ hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 1998 Aug; 8(8): 653-9.
  26. Moster ML, Bosley TM, Slavin ML: Thyroid ophthalmopathy presenting as superior oblique paresis. J Clin Neuroophthalmol 1992 Jun; 12(2): 94-7.
  27. Perros P, Crombie AL, Kendall-Taylor P: Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 1995; 42: 45-50.
  28. Prummel MF, Wiersinga WM: Smoking and risk of Graves’ disease [see comments]. JAMA 1993 Jan 27; 269(4): 479-82.
  29. Tallstedt L, Lundell G, Torring O: Occurrence of ophthalmopathy after treatment for Graves’ hyperthyroidism. The Thyroid Study Group [see comments]. N Engl J Med 1992 Jun 25; 326(26): 1733-8.
  30. Tellez M, Cooper J, Edmonds C: Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol 1992; 36: 291-4.
  31. Trokel S, Kazim M, Moore S: Orbital fat removal. Decompression for Graves orbitopathy. Ophthalmology 1993 May; 100(5): 674-82.
  32. von Basedow CA: Exophthalmos durch hypertrophie des cellgewebes in der augenhohle. Woechenschr Ges Heilk 1840; 6: 197,220.
  33. Wiersinga WM, Smit T, van der Gaag R: Clinical presentation of Graves’ ophthalmopathy. Ophthalmic Res 1989; 21: 73.
  34. Wilson WB, Prochoda M: Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance. Arch Ophthalmol 1995 Nov; 113(11): 1420-5.
  • Share/Bookmark
Neuroimaging of entrapment neuropathy
Mar 2nd, 2010 by Administrator

The author: Professor Yasser Metwally

http://yassermetwally.com


INTRODUCTION

March  2, 2010 —  Guided to the location of entrapment by the clinical and neurologic examination, MR imaging is used to detect objective imaging findings of nerve compression (7). Some of the peripheral nerves that are affected and the sites of entrapment include the median nerve in the carpal tunnel (1, 4), the ulnar nerve in the cubital tunnel (3, 5) or in Guyon’s canal, the lower trunk of the brachial plexus at the insertion of the anterior scalene muscle on the first rib (scalenus anticus syndrome) or at the crossing of a cervical rib (cervical rib syndrome) (6), the sciatic nerve at the greater sciatic foramen (piriformis syndrome), and the lateral femoral cutaneous nerve near the attachment of the inguinal ligament to the anterior superior iliac spine (meralgia paresthetica) (2). Compressive neuropathy or plexopathy may also result from hematoma or aneurysmal formation in certain locations: iliopsoas hematoma causing femoral neuropathy or lumbar plexopathy, depending on the extent of hemorrhage, and aneurysm of the abdominal aorta, internal iliac, or gluteal arteries causing lumbosacral plexopathy. Currently, the presence of localized abnormal T2 signal of the involved nerve on MR images has been the most reliable finding and is useful to confirm the clinical diagnosis, to eliminate the possibility of a mass lesion, and to help with surgical planning and postsurgical follow-up.

  • MR imaging in carpal tunnel syndrome

Since the 1980s, there has been a dramatic increase in the diagnosis of carpal tunnel syndrome (CTS), to the point where it is now recognized as the most common peripheral nerve entrapment syndrome, with an annual incidence of 50 to 150 cases per 100,000 individuals. CTS results from compression of the median nerve in the carpal tunnel . Patients develop insidious onset of paresthesias or numbness in a median nerve distribution in the hand. Pain is frequently present in the hand or wrist and may include the forearm, upper arm, or shoulder. Patients may complain of dropping things from their hands, most likely because of numbness, because weakness of the abductor pollucis brevis and opponens muscles is an uncommon and late finding. Symptoms are usually intermittent and provoked by flexion of the wrist while asleep, repetitive wrist movements, keyboard typing, prolonged wrist flexion or extension, or driving. Symptoms usually improve by shaking the hands, which is in itself a diagnostic test called the “flick test.” [8]

Click to enlarge figure

Figure 1. The carpal tunnel (Click to enlarge figure)

Most cases of carpal tunnel syndrome are either idiopathic, especially in the older population, or related to repetitive wrist movements, particularly in young adults. Various medical disorders may predispose individuals to this condition, however (Box 1). Acute or remote wrist trauma may lead to compression of the median nerve. Reduction of the carpal tunnel space available to the median nerve, leading to nerve compression, may occur in several disorders. Diseases associated with polyneuropathy, such as diabetes mellitus or renal failure, also leave the median nerve vulnerable to compression.

Box 1. Causes of carpal tunnel syndrome

  • Repetitive wrist activities

  • Idiopathic (increased frequency with increasing age)

  • Nerve susceptibility to compression

  • Amyloidosis

  • Concomitant mononeuropathy multiplex

  • Concomitant polyneuropathy

  • Diabetes mellitus

  • Hereditary neuropathy with liability to pressure palsy

  • Multiple myeloma

  • Renal failure

  • Reduced carpal tunnel space

  • Acromegaly

  • Anomalous muscles or tendons

  • Congenital small carpal tunnel

  • Generalized edema

  • Gout

  • Hypothyroidism

  • Mass lesions (eg, cyst, ganglion, lipoma, neurofibroma, or other tumors)

  • Mucolipidoses

  • Mucopolysaccharidoses

  • Osteophytes

  • Pregnancy

  • Tenosynovitis (eg, rheumatoid arthritis)

  • Wrist trauma

  • Acute fracture

  • Dislocation of the wrist or hand joint

  • Hematoma

  • Remote fracture

  • Swelling

  • Familial CTS

Various MR imaging findings have been described in patients who have carpal tunnel syndrome. These findings include the following: high signal on T2-weighted images, swelling of the nerve either proximal or distal to the point of maximal compression, flattening of the nerve within the tunnel, bowing of the flexor retinaculum, and thickening with increased signal of the flexor tendon sheaths and deep palmar bursa.

In addition to signal, MR imaging readily depicts nerve configuration. Frequently, the point of maximal compression within the carpal tunnel is at the hook of the hamate, where the cross-sectional area of the tunnel is usually smallest. The compressed nerve is usually swollen proximal to the point of maximal compression, and a dramatic change in caliber often indicates the site of entrapment. When nerve swelling occurs, there is usually prominence of the fascicular pattern, which is best seen on T2-weighted images

In patients with flexor tenosynovitis, axial MRI demonstrates bowing of the flexor retinaculum.  Inflamed synovium and tendon sheaths demonstrate low signal intensity on T1-weighted images and increased signal intensity on T2-weighted, T2*-weighted, and short tau inversion recovery (STIR) sequences.

Regardless of the etiology of carpal tunnel syndrome, changes in the median nerve are similar and include the following:


1- Diffuse swelling or segmental enlargement of the median nerve may be demonstrated (usually seen best at the level of the pisiform).

2- The median nerve may flatten (usually demonstrated best at the level of the hamate).

3- Palmar bowing of the flexor retinaculum may be noted (usually demonstrated best at the level of the hamate).

4- Increased T2-weighted signal intensity within the median nerve occurs, which is demonstrated best on axial fast spin-echo (FSE) T2-weighted images. If FSE signal sequences are not available, axial gradient-recalled echo (GRE) or inversion recovery (IR) sequences also are sensitive to the increased edema in the median nerve that accompanies carpal tunnel syndrome.

MRI also is useful in detecting and characterizing space-occupying lesions, such as neuromas, ganglion cysts, lipomas, and hemangiomas. Enlargement or swelling of the median nerve proximal to the carpal tunnel, termed a pseudoneuroma, has been documented using MRI.

Click to enlarge figure

Figure 2. Cross-section of the wrist obtained by Magnetic Resonance Imaging (MRI), showing the bones and soft tissues in great detail. A build-up of pressure in the wrist can lead to compression of the median nerve (seen as a medium-grey, oval structure) causing carpal tunnel syndrome – pain, a tingling sensation and numbness in the fingers. Indices of nerve compression are measured from the MRI scans. (Click to enlarge figure)

Flow-sensitive sequences or dynamic contrast-enhanced MRI can detect a circulatory disturbance causing carpal tunnel syndrome, which is a cause separate from deformation or compression of the median nerve.

Click to enlarge figure

Figure 3. Carpal tunnel: Normal findings of isointense-to-hypointense appearance of the median nerve on fast spin-echo T2-weighted MRI (arrow). Note the fairly well-defined nerve fascicles within the median nerve sheath. (Click to enlarge figure)

One of two abnormal patterns of median nerve enhancement is usually demonstrated: marked enhancement of the nerve (attributed to hypervascular edema) or noticeable lack of enhancement (attributed to nerve ischemia).

Click to enlarge figure

Figure 4. Carpal tunnel syndrome. Axial fast spin-echo T2-weighted MRI with fat saturation. Note the increased T2-weighted signal within the median nerve (arrow). A slightly increased cross sectional area of the nerve is noted but the nerve architecture is preserved, consistent with early or mild inflammation. (Click to enlarge figure)

As with the symptoms of carpal tunnel syndrome, MRI findings in the syndrome may vary with wrist position: flexion or extension of the wrist during the scan can alter the visualization of the median nerve from marked enhancement to complete lack of enhancement, presumably because of mechanical obstruction of blood flow to the  nerve. These actions are associated with exacerbation of clinical symptoms.

Click to enlarge figure

Figure 5. Carpal tunnel syndrome. Fast spin-echo T2-weighted MRI illustrates more pronounced increased signal within the median nerve (arrow). Note the small amount of fluid within the carpal tunnel, a secondary sign of inflammation. Slightly less optimal fat saturation is noted than on other images, which is a common occurrence. (Click to enlarge figure)

Click to enlarge figure

Figure 6. Carpal tunnel syndrome. Axial fast spin-echo T2-weighted MRI with greater increase in signal and loss of definition within the nerve (arrow). Inflammatory change is noted within the carpal tunnel, adjacent to the flexor digitorum superficialis tendons. The appearance is consistent with pronounced inflammatory change within the carpal tunnel. (Click to enlarge figure)

  • Surgical management

Attempted surgical therapy for carpal tunnel syndrome may result in incomplete release of the flexor retinaculum. This can be detected by a residual increase in T2 signal of the median nerve within the carpal tunnel and by direct visualization of the still-connected fibers of the retinaculum.  Transverse carpal ligament release from the hook of the hamate can cause the contents of the carpal canal and/or the flexor tendons to demonstrate a volar convexity caused by the loss of the normal roof support of the flexor retinaculum.  In addition to incomplete release of the flexor retinaculum, postoperative MRI changes in failed carpal tunnel surgery include excessive fat within the carpal tunnel, neuromas, scarring, and persistent neuritis. A normal postoperative finding is widening of the fat stripe posterior to the flexor digitorum profundus tendons.  MRI studies following carpal tunnel release may demonstrate an increase in carpal tunnel volume of up to 24%, often accompanied by a change in shape from oval to circular, resulting in increased anteroposterior and mediolateral diameters.

  • Summary

In patients who have clinically diagnosed carpal tunnel syndrome without symptoms or signs to suggest other disorders that can mimic carpal tunnel syndrome, it remains controversial as to whether performing nerve conduction studies is necessary or cost-effective. Even less evidence exists regarding the cost-effectiveness of imaging for carpal tunnel syndrome. MR imaging reliably depicts normal carpal tunnel anatomy, including the median and ulnar nerves and their intraneural fascicular structure. It can also identify pathologic nerve compression and mass lesions, such as ganglion cysts, which compress nerves. Currently, MR imaging is probably most commonly used to image patients who have ambiguous electrodiagnostic studies and clinical examinations. MR diffusion-weighted imaging of peripheral nerves might prove to be the most sensitive imaging sequence for the detection of early nerve dysfunction.

Electrodiagnostic studies are likely to remain the pivotal diagnostic examination in patients with suspected carpal tunnel syndrome for the foreseeable future. With advances in imaging software and hardware, however, high-resolution MR imaging of peripheral nerves will become faster, cheaper, and likely more accurate, possibly paving the way for an expanded role in the diagnosis of this common syndrome.


References

  1. Britz G, West G, Dailey A, et al. Magnetic resonance imaging in evaluating and treating peripheral nerve problems. Perspect Neurol Surg 1995;6:53– 66
  2. Sunderland S. In: Nerves and Nerve Injuries. Baltimore: Williams & Wilkins; 1968:25–57, 733–1112
  3. Britz G, Haynor D, Kuntz C, et al. Ulnar nerve entrapment at the elbow: correlation of magnetic resonance imaging, clinical, electrodiagnostic, and intraoperative findings. Neurosurgery 1996;38: 458–465
  4. Middleton W, Kneeland J, Kellman G, et al. MR imaging of the carpal tunnel: normal anatomy and preliminary findings in the carpal tunnel syndrome. AJR Am J Roentgenol 1987;148:307–316
  5. Rosenberg Z, Beltran J, Cheung Y, Ro S, Green S, Lenzo S. The elbow: MR features of nerve disorders. Radiology 1993;188:235–240
  6. Panegyres P, Moore N, Gibson R, Rushworth G, Donaghy M. Thoracic outlet syndromes and magnetic resonance imaging. Brain 1993;116:823– 841
  7. Beltran J, Rosenberg Z. Diagnosis of compressive and entrapment neuropathies of the upper extremity: value of MR imaging. AJR Am J Roentgenol 1994;163:525–531
  8. 1. Metwally, MYM: Textbook of neuroimaging, A CD-ROM publication, (Metwally, MYM editor) WEB-CD agency for electronic publication, version 10.1a January 2010 [Click to have a look at the home page]

  • Share/Bookmark
Radiological quiz
Feb 28th, 2010 by Administrator

The author: Professor Yasser Metwally

http://yassermetwally.com


INTRODUCTION

January 28, 2010 — Radiological quiz

Radiological quiz. What is your diagnosis

Click to download the answer in PDF format

Click to download slide show in PDF format


References

  1. Metwally, MYM: Textbook of neuroimaging, A CD-ROM publication, (Metwally, MYM editor) WEB-CD agency for electronic publication, version 11.1a January 2010 [Click to have a look at the home page]
  • Share/Bookmark
Neuroimaging of Anxiety disorders
Feb 7th, 2010 by Administrator

The author: Professor Yasser Metwally

http://yassermetwally.com


INTRODUCTION

February 7, 2010 — This section focuses on data pertaining to generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, and posttraumatic stress disorder (PTSD).

Volumetric MRI has been used to show that adolescents who have generalized anxiety disorder have larger white matter and gray matter volumes in the superior temporal gyrus. [1] A right greater than left asymmetry also was noted in this structure and the percent of asymmetry correlated significantly with child report ratings on the Screen for Child Anxiety Related Emotional Disorders scale. This finding is suggestive of structural changes developing early on in the disease process. It remains to be seen whether or not they occur pre-morbidly.

Functional MRI has been used to evaluate intolerance to uncertainty, a major component of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder. Intolerance to uncertainty correlates positively with bilateral activation of the insula. [2] It may be that increased affective response to situations with uncertain outcomes with corresponding activation of the insula is a trait marker for certain anxiety disorders.

In this area, the data are approaching greater clinical usefulness in that prediction of response to treatment has been demonstrated. In adults who had generalized anxiety disorder, response to venlafaxine was predicted by greater pretreatment reactivity to fearful faces in the rostral anterior cingulate cortex and lesser reactivity in the amygdala as measured by functional MRI. [3] In children and adolescents who had generalized anxiety disorder, this modality was used to predict response not only to medication but also to cognitive behavioral therapy. [4] In this group there was a significant negative association between degree of left amygdala activation and measures of post-treatment symptom improvement.

Disordered caudate nuclear metabolism has long been implicated in the pathophysiology of obsessive-compulsive disorder. [5] In general, alterations of frontostriatal circuitry have been found in various studies. It has been suggested that discordant findings may be the result of different subtypes of the disorder (hoarding, germ phobia, and so forth) with different neurobiologic underpinnings.

Voxel-based morphometry has been used to show significantly lower gray matter density in pediatric obsessive-compulsive disorder patients compared with healthy control subjects in the left anterior cingulate cortex and bilateral medial superior frontal gyrus. [6] When compared with their unaffected siblings, patients displayed significantly greater gray matter volume in the right putamen. In adults, this technique has demonstrated that the dorsal cortical regions of healthy control subjects have significantly greater gray matter volumes than that of patients who have obsessive-compulsive disorder and that in the midbrain bilaterally this relationship is reversed. [7] Furthermore, greater total obsessive-compulsive symptoms were highly significantly related to larger gray matter volumes in the bilateral midbrain.

Response to treatment has been another fruitful area of investigation in obsessive-compulsive disorder. Recently, F18-flourodeoxyglucose (FDG)–positron emission tomography (PET) was used to demonstrate efficacy after only 4 weeks of intensive individual cognitive behavioral therapy. [8] Patients showed significant bilateral decreases in normalized thalamic metabolism and, unexpectedly, an increase in right dorsal anterior cingulate cortex activity that correlated strongly with degree of symptom improvement. It has been postulated that response to intensive cognitive-behavioral therapy may require activation of the dorsal anterior cingulate cortex because of its role in reassessment and suppression of negative emotions.

PTSD has proved another fruitful area in the neuroimaging literature. Several factors may have a bearing on the outcomes, including the type of trauma (eg, physical, sexual, or psychologic), the brain’s maturational stage at the time of the trauma, and the possibility of predisposing vulnerability. Over the past decade, consensus has arisen regarding the role of the amygdala, medial prefrontal cortex, and hippocampus in PTSD. [9] Specifically, amygdala responsivity is positively associated with symptom severity whereas that of the medial prefrontal cortex is inversely associated with the same. The hippocampus in PTSD has been shown to possess decreased volumes and deficiencies in neural and functional integrity.

Recent structural imaging has shown that children who have maltreatment-related PTSD had significantly smaller cerebellar volumes compared with healthy control subjects. [10] Furthermore, cerebellar volumes negatively correlated to the duration of trauma and positively correlated with age of onset of trauma. This adds to the consensus regarding the cerebellums importance in cognitive and emotional development.

Another pediatric study has yielded insights into the complex interplay of stress and developmental damage to the brain. Baseline cortisol levels and PTSD symptoms predicted hippocampal reduction in 15 children over an ensuing 12- to 18-month interval. [1] This is some of the earliest human evidence confirming preclinical data that the glucocorticoids secreted during stress can be neurotoxic to the hippocampus.

A unique group of Vietnam War veterans has afforded the opportunity to assess whether or not the characteristic findings of PTSD reflect the underlying cause or a secondary effect of the disorder. Veterans who had suffered brain injury and emotionally traumatic events exhibited a reduced occurrence of PTSD if they had damage to the ventromedial prefrontal cortex or the anterior temporal area that included the amygdala. [12] This suggests that these two structures are critically involved in the pathogenesis of PTSD.

The interaction of PTSD with other pathologic states also has been addressed. Blood oxygenation level–dependent functional MRI has been used to show reduced pain sensitivity in male veterans suffering from PTSD. [13] Compared to veterans matched for age and region of deployment, patients revealed increased activation in the left hippocampus and decreased activation in the ventrolateral prefrontal cortex bilaterally and in the right amygdala in response to nociception. The patients also rated fixed-temperature noxious conditions as less painful than did control subjects.

Reflecting on the anxiety disorders in general, it has been suggested that fear is a major component and that the amygdala is critical for the acquisition and expression of that emotion. It is hypothesized, however, that it is activity in the prefrontal cortex that controls what individuals who have an anxiety disorder ultimately experience. [14] PTSD, panic disorder, and the phobias—those disorders involving intense fear—seem characterized by underactivity in the prefrontal cortex, thereby disinhibiting the amygdala. Conversely, disorders involving worry and rumination—generalized anxiety disorder and obsessive-compulsive disorder—seem characterized by overactivity of the prefrontal cortex.


References

  1. De Bellis MD, Keshavan MS, Shifflett H, et al. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry. 2002;51(7):553–562.
  2. Simmons A, Matthews SC, Paulus MP, et al. Intolerance of uncertainty correlates with insula activation during affective ambiguity. Neurosci Lett. 2008;430(2):92–97.
  3. Whalen PJ, Johnstone T, Somerville LH, et al. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry. 2008;63(9):858–863.
  4. McClure EB, Adler A, Monk CS, et al. FMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology. 2007;191(1):97–105.
  5. Baxter LR, Phelps ME, Mazziotta JC, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1993;50(6):498–501.
  6. Gilbert AR, Keshavan MS, Diwadkar V, et al. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett. 2008;435(1):45–50.
  7. Gilbert AR, Mataix-Cols D, Almeida JR, et al. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord [Epub ahead of print].
  8. Saxena S, Gorbis E, O’Neill J, et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry [Epub ahead of print].
  9. Shin LM, Rauch SL, Pitman RK. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci. 2006;1071:67–79.
  10. De Bellis MD, Kuchibhatla M. Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry. 2006;60(7):697–703.
  11. Carrion VG, Weems CF, Reiss AL. Stress predicts brain changes in children: a pilot longitudinal study on youth stress, posttraumatic stress disorder, and the hippocampus. Pediatrics. 2007;119(3):509–516.
  12. Koenigs M, Huey ED, Raymont V, et al. Focal brain damage protects against post-traumatic stress disorder in combat veterans. Nat Neurosci. 2008;11(2):232–237.
  13. Geuze E, Westenberg HG, Jochims A, et al. Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry. 2007;64(1):76–85.
  14. Berkowitz RL, Coplan JD, Reddy DP, et al. The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci. 2007;18(3–4):191–207.
  • Share/Bookmark
»  Substance: WordPress   »  Style: Ahren Ahimsa
© Copyright Yasser Metwally, All rights reserved